Skip to main content
SpringerLink
Log in

Pharmaka bei chronisch entzündlichen Darmerkrankungen

  • Chapter
  • First Online:
Pharmakologie und Toxikologie

  • 31k Accesses

Zusammenfassung

Zu den chronisch entzündlichen Darmerkrankungen im engeren Sinne gehören der Morbus Crohn und die Colitis ulcerosa. Beide Erkrankungen gehen mit einer erheblichen Beeinträchtigung der Lebensqualität einher.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Weiterführende Literatur

  • Abraham C, Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361:2066–2078

    Article  CAS  Google Scholar 

  • Akobeng AK, Gardener E (2005) Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn’s disease. Cochrane Database Syst Rev 1:CD003715

    Google Scholar 

  • Akobeng AK, Zachos M (2004) Tumor necrosis factor-alpha antibody for induction of remission in Crohn’s disease. Cochrane Database Syst Rev 1:CD003574

    Google Scholar 

  • Baumgart DC, Sandborn WJ (2012) Crohn’s disease. Lancet 380:1590–1605

    Article  Google Scholar 

  • Ford AC, Moayyedi P, Hanauer SB (2013) Ulcerative colitis. BMJ 346:f432

    Article  Google Scholar 

  • Korzenik JR, Podolsky DK (2006) Evolving knowledge and therapy of inflammatory bowel disease. Nat Rev Drug Discov 5:197–209

    Article  CAS  Google Scholar 

  • Nielsen OH, Ainsworth MA (2013) Tumor necrosis factor inhibitors for inflammatory bowel disease. N Engl J Med 369:754–762

    Article  CAS  Google Scholar 

  • Peyrin-Biroulet L, Desreumaux P, Sandborn WJ, Colombel J-F (2008) Crohn’s disease: beyond antagonists of tumour necrosis factor. Lancet 372:67–81

    Article  CAS  Google Scholar 

  • Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF (2017) Ulcerative colitis. Lancet 389:1756–1770

    Article  Google Scholar 

  • Wehkamp J, Götz M, Herrlinger K, Steurer W, Stange EF (2016) Chronisch entzündliche Darmerkrankugen. Dtsch Arztebl Int 113:72–82

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Pharmakologie, Max-Planck-Institut für Herz- und Lungenforschung, Bad Nauheim, Deutschland

    Stefan Offermanns

Authors
  1. Stefan Offermanns
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan Offermanns .

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Offermanns, S. (2020). Pharmaka bei chronisch entzündlichen Darmerkrankungen. In: Pharmakologie und Toxikologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-58304-3_47

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-58304-3_47

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-58303-6

  • Online ISBN: 978-3-662-58304-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation